Braskem SA ADR (BAK)

NYSE · Basic Materials · Chemicals · Brazil

Braskem SA ADR is a micro cap company (market value under $300 million) in the Chemicals industry.

Intrinsic value, DCF valuation, financial health and value investing analysis for the Braskem SA ADR stock.

Our verdict on BAK

Undervalued: intrinsic value $5.79 per share, market price $1.16, margin of safety 80.0% (as of 2026-10-30).

Its through-the-cycle earnings (4.4% median margin), capitalised at 5.3% with no growth, values the shares at $5.79; the price of $1.16 is 80% below that value.

Leak Score: 61/100 on 8 of 12 signals (Faint Leak).

Browse

Peers in Chemicals

All 16 Chemicals stocks

Is BAK undervalued or overvalued?

BAK is undervalued (as of the 2026-10-30 close). Its through-the-cycle earnings (4.4% median margin), capitalised at 5.3% with no growth, values the shares at $5.79; the price of $1.16 is 80% below that value.

What is the intrinsic value of BAK?

$5.79 per share (as of the 2026-10-30 close), against a market price of $1.16. That is a margin of safety of 80.0%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.

What is Braskem SA ADR's Leak Score?

61 out of 100, which we rate "Faint Leak", on 8 of 12 value investing signals.